Skip to content
Application 209872
- Type
- ANDA
- Sponsor
- STI PHARMA LLC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 25MG | No | No |
| 002 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 50MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 54879-021 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | STI Pharma LLC | ANDA | Current |
| 54879-021 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | STI Pharma LLC | ANDA | Current |
| 54879-021 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | STI Pharma LLC | ANDA | Current |
| 54879-021 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | STI Pharma LLC | ANDA | Current |
| 54879-021 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | STI Pharma LLC | ANDA | Current |
| 54879-022 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | STI Pharma LLC | ANDA | Current |
| 54879-022 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | STI Pharma LLC | ANDA | Current |
| 54879-022 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | STI Pharma LLC | ANDA | Current |
| 54879-022 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | STI Pharma LLC | ANDA | Current |
| 54879-022 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | STI Pharma LLC | ANDA | Current |